Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB

In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Wenyuan, Huang Beibei, Shen Qiang, Jiang Shouwei, Jin Kun, Ning Ling, Liu Lei, Li Lei
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
R
Acceso en línea:https://doaj.org/article/8ece37f7a0274aa893d3bd961bcbed90
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ece37f7a0274aa893d3bd961bcbed90
record_format dspace
spelling oai:doaj.org-article:8ece37f7a0274aa893d3bd961bcbed902021-12-05T14:10:54ZPersistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB2391-546310.1515/med-2021-0283https://doaj.org/article/8ece37f7a0274aa893d3bd961bcbed902021-05-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0283https://doaj.org/toc/2391-5463In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report a case of SARS-CoV-2 infection with intermittent viral polymerase chain reaction (PCR)-positive for >4 months after clinical rehabilitation. A 35-year-old male was diagnosed with COVID-19 pneumonia with fever but without other specific symptoms. The treatment with lopinavir-ritonavir, oxygen inhalation, and other symptomatic supportive treatment facilitated recovery, and the patient was discharged. However, his viral PCR test was continually positive in oropharyngeal swabs for >4 months after that. At the end of June 2020, he was still under quarantine and observation. The contribution of current antivirus therapy might be limited. The prognosis of COVID-19 patients might be irrelevant to the virus status. Thus, further investigation to evaluate the contagiousness of convalescent patients and the mechanism underlying the persistent existence of SARS-CoV-2 after recovery is essential. A new strategy of disease control, especially extending the follow-up period for recovered COVID-19 patients, is necessary to adapt to the current situation of pandemic.Li WenyuanHuang BeibeiShen QiangJiang ShouweiJin KunNing LingLiu LeiLi LeiDe Gruyterarticlecovid-19sars-cov-2convalescencecoronaviruscase reportMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 749-753 (2021)
institution DOAJ
collection DOAJ
language EN
topic covid-19
sars-cov-2
convalescence
coronavirus
case report
Medicine
R
spellingShingle covid-19
sars-cov-2
convalescence
coronavirus
case report
Medicine
R
Li Wenyuan
Huang Beibei
Shen Qiang
Jiang Shouwei
Jin Kun
Ning Ling
Liu Lei
Li Lei
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
description In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report a case of SARS-CoV-2 infection with intermittent viral polymerase chain reaction (PCR)-positive for >4 months after clinical rehabilitation. A 35-year-old male was diagnosed with COVID-19 pneumonia with fever but without other specific symptoms. The treatment with lopinavir-ritonavir, oxygen inhalation, and other symptomatic supportive treatment facilitated recovery, and the patient was discharged. However, his viral PCR test was continually positive in oropharyngeal swabs for >4 months after that. At the end of June 2020, he was still under quarantine and observation. The contribution of current antivirus therapy might be limited. The prognosis of COVID-19 patients might be irrelevant to the virus status. Thus, further investigation to evaluate the contagiousness of convalescent patients and the mechanism underlying the persistent existence of SARS-CoV-2 after recovery is essential. A new strategy of disease control, especially extending the follow-up period for recovered COVID-19 patients, is necessary to adapt to the current situation of pandemic.
format article
author Li Wenyuan
Huang Beibei
Shen Qiang
Jiang Shouwei
Jin Kun
Ning Ling
Liu Lei
Li Lei
author_facet Li Wenyuan
Huang Beibei
Shen Qiang
Jiang Shouwei
Jin Kun
Ning Ling
Liu Lei
Li Lei
author_sort Li Wenyuan
title Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
title_short Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
title_full Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
title_fullStr Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
title_full_unstemmed Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
title_sort persistent sars-cov-2-positive over 4 months in a covid-19 patient with chb
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/8ece37f7a0274aa893d3bd961bcbed90
work_keys_str_mv AT liwenyuan persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT huangbeibei persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT shenqiang persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT jiangshouwei persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT jinkun persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT ningling persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT liulei persistentsarscov2positiveover4monthsinacovid19patientwithchb
AT lilei persistentsarscov2positiveover4monthsinacovid19patientwithchb
_version_ 1718371615692029952